This protocol details a method to isolate antigen presenting cells from human thymus via different steps of enzymatic digestion of the tissue followed by density centrifugation of the single cell suspension and finally magnetic and/or FACS sorting of the cell populations of interest.
In this protocol we provide a method to isolate dendritic cells (DC) and epithelial cells (TEC) from the human thymus. DC and TEC are the major antigen presenting cell (APC) types found in a normal thymus and it is well established that they play distinct roles during thymic selection. These cells are localized in distinct microenvironments in the thymus and each APC type makes up only a minor population of cells. To further understand the biology of these cell types, characterization of these cell populations is highly desirable but due to their low frequency, isolation of any of these cell types requires an efficient and reproducible procedure. This protocol details a method to obtain cells suitable for characterization of diverse cellular properties. Thymic tissue is mechanically disrupted and after different steps of enzymatic digestion, the resulting cell suspension is enriched using a Percoll density centrifugation step. For isolation of myeloid DC (CD11c+), cells from the low-density fraction (LDF) are immunoselected by magnetic cell sorting. Enrichment of TEC populations (mTEC, cTEC) is achieved by depletion of hematopoietic (CD45hi) cells from the low-density Percoll cell fraction allowing their subsequent isolation via fluorescence activated cell sorting (FACS) using specific cell markers. The isolated cells can be used for different downstream applications.
The thymus is the organ in which T cell development occurs. Its relative and absolute size decreases with age when it becomes successively replaced by fat although thymic activity can still be detected in the old age. Its importance for the immune response was demonstrated in the early 1960s1.
The T cell repertoire is shaped through the interaction of T cell receptors with peptide-MHC complexes on different kinds of thymic APC, which provide survival or death cues to developing T cells, resulting in a functional and largely self-tolerant T cell repertoire2.
Approximately 98% of the cells in the human thymus are developing T cells referred to as thymocytes. The remaining 2% consist of a number of different cell types, including a variety of TEC (cortical, medullary, subcapsular), myeloid and plasmacytoid DC (mDC, pDC), macrophages, B cells, mature re-circulating T cells, granulocytes, fibroblasts, endothelial cells and very rare epithelial cells with an expression phenotype resembling that of cells from other tissues such as muscle, neurons and respiratory epithelium (Figure 1). Of these, TEC and DC are the major APC types found in a normal thymus. In recent years, purification of these APC types for culture and molecular profiling has gained more and more interest. Due to their low frequency, isolation of any of these cell types for detailed analysis requires an efficient, reproducible and cost-effective procedure. The method presented here is a modification from previously published studies3,4.
As with any other tissue, cell extraction from the thymus can be achieved by enzymatically disaggregating the cell-cell and cell-matrix interaction networks, in order to obtain a suspension of single cells. There are certain parameters like good dissociation efficiency, cell yield, cell viability and retention of cell surface markers that are crucial and need to be optimized for the successful isolation of these rare cell populations.
In this protocol, isolation of DC and TEC subsets is performed by making a single-cell suspension of the tissue by mechanical disruption and enzymatic digestion. We use Collagenase A from Clostridium histolyticum, which has a balanced ratio of different enzyme activities, to break down the native collagen that holds the tissue together. DNase I is included in the enzyme solution to reduce cell aggregation due to free DNA from dead cells (thymocytes are very sensitive).We also provide an alternative approach to the typical enzymatic tissue digestion involving mechanical and enzymatic tissue treatment assisted by a tissue dissociator. The single cell suspension is then subjected to a single Percoll density centrifugation for enrichment of low density fraction (LDF) of cells. From this fraction of cells, DC can be isolated by staining for DC-surface markers (i.e. CD11c+) and using magnetic separation or fluorescence-activated cell sorting (FACS). Unlike the lymphoid cells comprising the vast majority of cells in the thymus, TEC do not express CD45 at high levels, but are positive for the epithelial cell adhesion molecule EpCAM. cTEC can be distinguished from medullary TEC by the expression of a yet undefined antigen recognized by the CDR-2 (cortical dendritic reticulocyte-2) antibody4,5 and somewhat lower EpCAM expression. The differential co-expression of EpCAM and CDR2 allows the efficient isolation of these TEC subsets via high-speed cell sorting6.
The protocol presented here is optimized for human thymic tissue. The duration of the procedure depends on the amount of tissue and the ability of the experimenter as well as the speed of the cell sorter, if FACS sorting is used. Normally, the protocol for the isolation of DC can be completed within 5-6 hr and for the isolation of TEC in 8-10 hr. The isolation of DC and TEC subsets from thymic tissue is time sensitive. The faster the isolation procedure, the better the condition of the cells. Finally, the isolated cells can be used for further investigations like comparative studies of mRNA and protein expression, PCR experiments, protein isolation, molecular profiling (i.e. transcriptomics, micro RNA analysis) as well as cell culture6.
Ethics Statement
In order to be able to work with human thymus tissue the researcher needs to obtain approval from the local ethics committee or responsible authorities as well as an informed written consent of the donor (or usually his or her parents, since tissue is usually obtained from underage children). Furthermore, all human tissues should be handled as being potentially infectious and appropriate measures should be taken, such as working with gloves, etc.
1. Preparation of Tools, Enzyme Solutions, and Buffers
Perform the following preparative steps prior to beginning the protocol.
2. Preparation of the Tissue
The processing of the tissue should be performed using sterile reagents and work in a laminar flow cabinet. Before the procedure begins, prepare the following reagents and equipment:
Note: the duration of this step depends on the condition and size of the tissue. Approximately 20-30 min is reasonable time needed for a medium size piece of tissue in good condition (~5 cm in width).
Note: For reproducibility of results, tissue should be cut into pieces of uniform size.
Tip: A sterile cell culture scraper can be used to concentrate all tissue pieces at one side of the dish then tilt the dish (45° angle) and aspirate the supernatant. Replace with fresh PBS and repeat this procedure until the supernatant is relatively transparent. Perform last wash with RPMI plain.
3. Preparation of Single Cell Suspension from Thymus Tissue
Here, two alternative approaches for this step are described. The first approach describes a typical enzymatic tissue digestion (section 3.1) while the second involves mechanical and enzymatic tissue treatment assisted by a tissue dissociator (section 3.2).
This protocol is optimized for the processing of tissue samples weighing 5 g. For larger or smaller tissue samples, adjust enzyme volumes accordingly.
3.1 Typical enzymatic tissue digestion to obtain a single cell suspension
Note: in a 50 ml tube digest up to 10 g of tissue. Adjust enzyme volume accordingly.
Note: the incubation steps can be performed either in a thermal incubator with a rotation unit, or in a 37 °C bacterial incubator with a shaker.
Note: thymic tissues can vary in their composition, especially with age, which affects the digestion efficiency and the generation of a single-cell suspension.
Note: The tissue may not be completely digested after these three rounds of digestions. Age and overall condition of the tissue are two parameters that influence the dissociation efficiency of the thymus tissue.
Tip: Cell pellets are quite loose, so take care when discarding/aspirating supernatant.
3.2 Mechanical and enzymatic tissue treatment assisted by a tissue dissociator
Using the tissue dissociator approach the tissue digestion steps can be reduced to half of the time needed with the approach described above (section 3.1). The following protocol is a modified version of that used to dissociate mouse thymus tissue for the isolation of TEC7,8.
Note: Using this approach, after this last digestion step the tissue is usually completely dissociated and no undigested tissue fragments are observed.
4. Enrichment of LDF of Cells Using Percoll-density Separation
After enzymatic digestion of the tissue, total thymic single cell suspensions are subjected to a single Percoll density centrifugation step to enrich for the LDF cells. The LDF of cells is highly enriched for APC. Both DC and TEC are detected in this fraction of cells.
Preparation of Percoll solution to a final density of 1.07 g/ml (ρ = 1.07) | ||||
Tube No. | 1 | 2 | 3 | 4 |
Undiluted Percoll (ρ = 1.130) (ml) | 2.96 | 5.92 | 8.88 | 11.84 |
1.5 M NaCl (ml) | 0.6 | 1.20 | 1.8 | 2.4 |
distilled H2O (ml) | 2.44 | 4.88 | 7.32 | 9.76 |
Volume of final working dilution | 6 ml | 12 ml | 18 ml | 24 ml |
Tip: Percoll is light sensitive and in addition it should be kept cold. Prepare first the mixture containing the NaCl and H2O (RT) and add undiluted Percoll last, just before resuspending the cells in the Percoll solution.
Note: Percoll density might vary between different suppliers and batches! If the density of the undiluted Percoll solution is not equal to 1.130 g/ml, use the instructions supplied by the manufacturer to calculate the exact amounts of Percoll and H2O required to get a final density of 1.07 g/ml.
Note: At this stage, you may observe that cells aggregated in the suspension (especially with samples from children of older age). Cell clumps are indication of cell death and result from the release of DNA from the dying cells that can stick cells together. In such a case, add DNase I into the sample (50 μg/ml) and incubate it for up to 20 min at RT (gently invert every 5 min) to digest the free DNA molecules.
5. Isolation of Thymic mDC
After APC enrichment (via Percoll separation), mDC can be efficiently isolated from the LDF following the first and second round of enzymatic digestions. The following protocol is a modified version of magnetic cell separation for the isolation of mDC (CD11c+).
Note: Titration experiments are recommended for optimal results.
Note: CD11c+mDC may also be isolated using a FACS sorter.
6. Enrichment of CD45lo/neg Cells for Cell Sorting of TEC
For isolation of TEC, cells can be pre-enriched by depletion of CD45hi cells using CD45 microbeads, in order to speed up their isolation through cell sorting.
Use single cell suspension obtained from the 3rd digestion step (3.1.14) and subsequently separated by Percoll centrifugation.
Note: By using a lower amount of the microbeads we pre-enrich cells for both CD45lo and CD45neg cells. Titration is recommended for optimal results.
7. Stain Cells for Fluorescence Activated Cell Sorting
Sample | Sample type | Antibody | Cell Number | Total volume |
1. unstained | control | 1 x 106 | 50 μl | |
2.scc*-Pacific Blue | control | CD45-Pacific Blue | 1 x 106 | 50 μl |
3. scc-APC | control | CD3-APC | 1 x 106 | 50 μl |
4.scc-Alexa 488 | control | CD8-Alexa 488 | 1 x 106 | 50 μl |
5. Cell sorting | analyte | CD45-Pacific Blue EpCAM-APC CDR2-Alexa 488 |
10 x 106 – 50 x 106 | 500 μl 10 x 106 cells/100 μl |
Notes:
8. Isolation of TEC by Fluorescence Activated Cell Sorting
TEC subsets can be sorted from the CD45lo/neg fraction as EpCAMhiCDR2– (mTEC) or EpCAMlo CDR2+ (cTEC).
Note: During sorting in order to prevent cells from sticking to the sides of the collection tube, the tube can be pre-coated by filling it up with 50% FCS in PBS and incubated at RT for 30 min. Discard the coating solution before adding collection media.
As starting material in this protocol we use thymus tissue removed from children undergoing corrective cardiovascular surgery (Department of Thoracic and Cardiovascular Surgery, University Clinic Tuebingen) obtained after informed consent and under institutional guidelines. This discarded material can vary greatly in size from 2-30 g or more. The number of mDC and TEC subsets (cTEC and mTEC) that are obtained depends on the size as well as the age of the thymus tissue sample used for isolation.
Figure 2 shows a rather large piece of tissue (~9 cm) obtained from a six year old child. An important first preparative step in this protocol is the cleaning of the tissue from undesirable parts (indicated by white arrows).
Thymus tissue was treated as outlined in sections 2 and 3.1 of the protocol to obtain a single cell suspension which was separated using a single Percoll density centrifugation step While the single cell suspension contains approximately 3% of HLA-DR+ cells (Figure 3A), after Percoll centrifugation this percentage is increased in the low-density fraction (LDF), containing large-sized cells, to 15-40% while the high-density fraction (HDF) that consists mainly of uniform small-sized thymocytes contains virtually no such cells (Figure 3B). The fraction of interest (LDF), containing enriched APC was subsequently collected and washed to collect cells for use in subsequent isolation steps.
While thymic mDC can be identified by the expression of a number of surface markers, including CD11c9,10, pDC express markers such as BDCA-2, BDCA-4, CD45RA and CD12311,12. After enrichment of the LDF cells, both cell types constitute 2-10% of this fraction, allowing their efficient isolation also in larger numbers, either by magnetic cell separation or flow sorting of CD11c+ or BDCA-4+ cells6.
Figure 4 shows the efficient isolation of CD11c+ cells using the modified magnetic cell separation protocol described in section 5. After isolation, the purity of the CD11c+ DC was 93% as established by immunostaining of isolated cells. On average, the recovery of isolated CD11c+DC is 5 x 105-5 x 106 mDC per 109 total thymic cells. Table 1 shows data obtained from several individual thymus samples of different age and tissue weight with a range of input single cell suspensions as well as total LDF numbers and the subsequent CD11c+ yield and purity.
In the APC enriched fraction, only approximately 0.5% of the cells are CD45loEpCAM+ or CD45negEpCAM+. cTEC and mTEC can be sorted from the trypsin-digested CD45lo/neg enriched stromal cells as EpCAMloCDR2+ and EpCAMhiCDR2–, respectively as shown in Figure 5.
Figure 1. A simplified diagram of the cellular organization and composition of the human thymus. The thymus consists of thymocytes, at different maturation stages, and a heterogeneous cellular network referred to as the thymic stroma forming the thymic environment. The main cell types of the thymic stroma are mDC and pDC, epithelial cells (divided into two main categories according to their localization within the lobule: cortical, and medullary) and macrophages. Abbreviations: DC, dendritic cells; mDC, myeloid dendritic cells; pDC, plasmacytoid dendritic cells; Mφ, macrophage; mono, monocytes; cTEC, cortical epithelial cells; mTEC, medullary epithelial cells.
Figure 2. First preparative step of the tissue for single-cell preparation. Arrows point to the undesirable tissue parts that need to be discarded prior to the execution of the protocol.
Figure 3. Purification of thymic APC. FACS analysis of different stages of the purification procedure. Single cell suspensions of thymus tissue were obtained by mechanical disruption and serial enzymatic digestions and APC enriched (LDF cells) by Percoll-density separation. Cells before (A) and after (B) the Percoll-density separation were stained with HLA-DR-PE antibody to check for APC enrichment. Percentage range of HLA-DR+ cells typically observed is indicated.
Figure 4. Isolation of CD11c+ mDC. Thymus tissue was digested using Collagenase A/DNase I to create a single cell suspension. CD11c+mDC represent only a minor population of the single cell suspension (0.6%). After enrichment of the LDF cells via Percoll-density separation the percentage of CD11c+ cells increases to ~9%. The LDF cells were labeled with CD11c-PE antibody and subsequently isolated using magnetic beads (anti-PE). Reanalysis of the CD11c+ population directly after magnetic cell separation by FACS indicated 93% purity. Click here to view larger figure.
Figure 5. Enrichment of CD45lo/neg cells and subsequent sorting of TEC subsets. A) Representative dot plots showing percentages of CD45 negative/low thymic stromal cells in total single cell suspensions before and after Percoll density separation (9% and 16.2%, respectively). B) The LDF cells was depleted of CD45hi cells using magnetic beads and the TEC subsets sorted from the depleted fraction as EpCAMhiCDR2– (mTEC) or EpCAMloCDR2+ (cTEC).
CD11c+ mDC frequencies, cell yields and purities of different donors | |||||||
Donor | Age | Tissue weight | Total cells per sample | LDF cells per sample | CD11c+ % | CD11c+isolated per sample | CD11c+ purity |
1 | 5 days | 7 g | 1.45 x 109 | 9.5 x107 | 12.6 | 2.4 x 106 | 89% |
2 | 3 years | 15 g | 2 x 109 | 6.5 x107 | 4.3 | 1.9 x 106 | 81% |
3 | 21 days | 9 g | 2.6 x 109 | 22 x107 | 10.3 | 3.6 x 106 | 93% |
4 | 6 years | 13 g | 1.4 x 109 | 25.4 x107 | 4.2 | 5.7 x 106 | 82% |
5 | 5 days | 6.5 g | 1.3 x 109 | 16.2 x107 | 6 | 2.9 x 106 | 91% |
6 | 39 days | 3 g | 0.6 x 109 | 8 x107 | 3.4 | 1.3 x 106 | 80% |
Table 1. Numbers of total single cell suspension cells released after two rounds of digestion as well as yields of LDF cells after Percoll separation are shown for isolations performed in thymus samples of six individuals of different age and tissue weight. Frequencies of mDC were determined by flow cytometry based on CD11c expression in total LDF cells (APC enriched).Yield and purity of CD11c+ cells after magnetic bead separation are shown for each individual donor.
The protocol described here is a modification of the protocol published by Gotter et al4. Critical steps in the protocol are the condition and initial preparation of the tissue as well as the Percoll density separation. We strongly recommend to process the tissue as soon as possible after collection. It is important to work fast but thoroughly when cleaning and cutting the tissue. During the thymocyte wash described in step 2.3, it is crucial to find the right balance when applying pressure with the back of the syringe plunger on the tissue pieces as too vigorous and prolonged pressure can damage the stromal cells. Layering the medium on top of the Percoll solution/cell suspension without causing perturbations may also require some practice. After centrifugation, it is important to collect all the low density fraction cells as quickly as possible from the Percoll layer with a minimum amount of Percoll solution.
The overall cell yields and relative APC numbers can be very variable (see Table 1) and depend on the donor (especially with respect to age) and the preparative skills of the experimenter. For a brief overview, cell suspensions can be stained with HLA-DR and/or other markers following different steps of the protocol as desired. All antibodies used for phenotypic analysis should be titrated to achieve optimal results.
Due to the relatively low abundance of APC types in the thymus compared to thymoctyes, larger pieces of thymus might be required if higher numbers of isolated cells are desired.
If a tissue dissociator is available in the lab, this will considerably speed up tissue processing, but both variations described here work equally well. A relatively frequent problem might be clumping of the cells, especially during the steps between the Percoll separation and MACS/FACS sorting. In this case, a short DNase I digestion as described in the protocol will usually solve the problem. Since thymus tissue is successively replaced by fat tissue during aging, thymi from older donors might contain some fat, which will swim on top of the tube after centrifuging the single cell suspensions obtained from the different digestion steps. In such a case, fat should be removed with a pipette before continuing the protocol. For optimal results as well as economy reasons we advice to titrate not only the antibodies but also the anti-PE microbeads (sections 5 and 6). For isolation of TEC from mouse thymus, alternative enzyme mixtures have been described to enhance TEC yield8,13, but we have not tested them with human tissue.
In principle, other thymic APC and stromal cells like B cells and pDC can also be isolated from the LDF cells (following collagenase/DNase digestion and Percoll) by FACS/MACS sorting if the respective markers are known. For example, for pDC, BDCA-2, BDCA-4 and CD123 have been described as markers6,14. If analysis or isolation of thymocyte subsets is desired, we recommend using the cells released by squeezing (step 2.3), since they are quite pure and have undergone minimal manipulation.
The authors have nothing to disclose.
We are grateful to the surgeons of the Department of Thoracic and Cardiovascular Surgery, University Clinic Tuebingen for providing us with the thymus samples and Bruno Kyewski (DKFZ, Heidelberg, Germany) for providing the CDR2 antibody. We would also like to thank Hans-Jörg Bühring and Sabrina Grimm from the sorting facility (University of Tuebingen). This work was supported by the SFB 685 and the Hertie Foundation.
Reagents and Materials | |||
RPMI 1640 | PAA | E15-842 | |
Dulbecco's PBS | PAA | H15-002 | |
Fetal Bovine Serum-Gold | PAA | A15-151 | |
Bovine Serum Albumin | PAA | K41-001 | |
Collagenase A | Roche | 10 103 586 001 | |
DNase I, grade II bovine pancreatic | Roche | 10 104 159 001 | |
Trypsin-EDTA 10x in PBS | PAA | L11-001 | stock conc. 20 mg/ml |
Alexa Fluor 488 Protein Labelling kit | Molecular Probes | A-10235 | |
anti-human CDR2 (purified) | Bruno Kyewski, DKFZ- Heidelberg, Germany | labeled with Alexa Fluor 488 | |
anti-human CD45 (Pacific Blue) | Biolegend | 304022 | |
anti-human EpCAM (APC) | Miltenyi Biotec | 130-091-254 | |
anti-human CD11c (PE) | Miltenyi Biotec | 130-092-411 | |
anti-PE Microbeads | Miltenyi Biotec | 130-048-801 | |
anti-CD45 Microbeads, human | Miltenyi Biotec | 130-045-801 | |
LS columns | Miltenyi Biotec | 130-042-401 | |
gentleMACS C Tubes | Miltenyi Biotec | 130-093-237 | for tissue dissociator |
Percoll (density 1.130 g/ml) | GE Healthcare, Life Sciences | 17-0891-01 | |
Sterile distilled Water (DNAse/ RNAse free) | GIBCO | 10977-035 | |
Gamunex 10% | Tajecris-Biotherapeutics | G120052 | 1:10 pre-dilution, use 20 μl/1 x 106cells |
0.22 μm filter | Millex GS | SLGS033SS | Syringe driven |
Stericup filter unit | Millipore | SCGPU05RE | Pump driven |
50 ml PC oak ridge centrifuge tubes | Nalgene | 3118-0050 | 50 ml |
50 ml PP conical tubes | Becton Dickinson | 352070 | |
12 mm x 75 mm 5 ml test tubes | Becton Dickinson | 352058 | FACS stainings |
Cell strainer 70 μm | Becton Dickinson | 352350 | |
INSTRUMENTS | |||
Flow Cytometer-Sorter (BD FACSAriaTMIIu) | Becton Dickinson | ||
Sorvall Evolution R6 (rotor) | Kendro | ||
Rotator REAX 2 | Heidolph | ||
gentleMACS Dissociator | Miltenyi Biotec | 130-093 235 | tissue dissociator |